Viewing Study NCT05940402


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2026-01-28 @ 9:24 PM
Study NCT ID: NCT05940402
Status: COMPLETED
Last Update Posted: 2025-04-04
First Post: 2023-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module